SCYNEXIS (SCYX) Insider David Hastings Buys 2,875 Shares

David Hastings, an insider at SCYX, bought 2,875 shares on June 26, 2026. These transactions were not part of a pre-planned trading program. Shares of SCYX traded at $4.07 on Wednesday, reflecting market interest in the stock.

Other Institutional Activity in SCYX

Several institutional investors have shown interest in SCYX. Squadron Capital Management LLC opened a new position with 7,608,695 shares worth about $6,976,412. Heights Capital Management, Inc also initiated a stake, acquiring 2,086,960 shares valued at approximately $1,913,534. Kingdon Capital Management, L.L.C. entered with 1,982,491 shares, valued at $1,817,746. Meanwhile, Avidity Partners Management LP maintained its holdings at 2,081,660 shares, indicating no change in their position.

SCYNEXIS, Inc. Stock Down 8.7%

On Wednesday, SCYX shares traded around $4.07. Despite the absence of specific financial metrics like market cap or P/E ratio, the stock's trading activity has been noteworthy with several institutional investors taking new positions.

Insider Buying and Selling at SCYNEXIS, Inc.

On June 26, 2026, several insiders, including Armando Anido, Ann Hanham, and David Hastings, each bought 2,875 shares of SCYX. These purchases were not planned under Rule 10b5-1 plans, indicating personal decisions to acquire shares.

Analysts Set New Price Targets

Analysts have maintained a positive outlook on SCYX. On October 28, 2025, Guggenheim maintained a 'buy' rating with a $3.00 price target, while Ladenburg Thalmann & Co. has consistently held a 'buy' rating with a target of $7.50 as of May 10, 2024. Maxim Group reiterated a 'buy' rating with a $10.00 target on August 16, 2023.

Bottom Line

David Hastings' purchase of SCYX shares highlights ongoing insider interest in the company. Institutional investors are also taking new stakes, suggesting confidence in the company's prospects. Analysts continue to support SCYX with 'buy' ratings, although price targets vary. As always, these insider transactions and analyst opinions provide a snapshot of confidence but are not current investment recommendations.